Immunosuppression in Cervical Cancer with Special Reference to Arginase Activity

ABSTRACT: Introduction: Cervical cancer is characterized by an immunosuppressive microenvironment and a Th2-type cytokine profile. Expression of arginase (ASE), the enzyme that converts L-arginine into L-ornithine and urea, is stimulated by Th2-type cytokines. Objective: To assess the association of...

Full description

Autores:
Bedoya, Astrid Milena
Tate, David
Baena Zapata, Armando
Córdoba Gómez, Carlos Mario
Borrero Franco, Mauricio
Pareja, René
Rojas, Fredy
Patterson, John
Herrero, Rolando
Zea, Arnold
Sánchez Vásquez, Gloria Inés
Tipo de recurso:
Article of investigation
Fecha de publicación:
2014
Institución:
Universidad de Antioquia
Repositorio:
Repositorio UdeA
Idioma:
eng
OAI Identifier:
oai:bibliotecadigital.udea.edu.co:10495/32451
Acceso en línea:
https://hdl.handle.net/10495/32451
https://www.sciencedirect.com/science/article/pii/S0090825814012190?via%3Dihub
Palabra clave:
Uterine Cervical Neoplasms
Neoplasias del Cuello Uterino
Arginase
Arginasa
Arginine
Arginina
Cytokines
Citocinas
Th1-Th2 Balance
Balance Th1 - Th2
Colombia
Rights
openAccess
License
http://creativecommons.org/licenses/by-nc-nd/2.5/co/
id UDEA2_35019f6087697f9b568e783520ae2235
oai_identifier_str oai:bibliotecadigital.udea.edu.co:10495/32451
network_acronym_str UDEA2
network_name_str Repositorio UdeA
repository_id_str
dc.title.spa.fl_str_mv Immunosuppression in Cervical Cancer with Special Reference to Arginase Activity
title Immunosuppression in Cervical Cancer with Special Reference to Arginase Activity
spellingShingle Immunosuppression in Cervical Cancer with Special Reference to Arginase Activity
Uterine Cervical Neoplasms
Neoplasias del Cuello Uterino
Arginase
Arginasa
Arginine
Arginina
Cytokines
Citocinas
Th1-Th2 Balance
Balance Th1 - Th2
Colombia
title_short Immunosuppression in Cervical Cancer with Special Reference to Arginase Activity
title_full Immunosuppression in Cervical Cancer with Special Reference to Arginase Activity
title_fullStr Immunosuppression in Cervical Cancer with Special Reference to Arginase Activity
title_full_unstemmed Immunosuppression in Cervical Cancer with Special Reference to Arginase Activity
title_sort Immunosuppression in Cervical Cancer with Special Reference to Arginase Activity
dc.creator.fl_str_mv Bedoya, Astrid Milena
Tate, David
Baena Zapata, Armando
Córdoba Gómez, Carlos Mario
Borrero Franco, Mauricio
Pareja, René
Rojas, Fredy
Patterson, John
Herrero, Rolando
Zea, Arnold
Sánchez Vásquez, Gloria Inés
dc.contributor.author.none.fl_str_mv Bedoya, Astrid Milena
Tate, David
Baena Zapata, Armando
Córdoba Gómez, Carlos Mario
Borrero Franco, Mauricio
Pareja, René
Rojas, Fredy
Patterson, John
Herrero, Rolando
Zea, Arnold
Sánchez Vásquez, Gloria Inés
dc.subject.decs.none.fl_str_mv Uterine Cervical Neoplasms
Neoplasias del Cuello Uterino
Arginase
Arginasa
Arginine
Arginina
Cytokines
Citocinas
Th1-Th2 Balance
Balance Th1 - Th2
Colombia
topic Uterine Cervical Neoplasms
Neoplasias del Cuello Uterino
Arginase
Arginasa
Arginine
Arginina
Cytokines
Citocinas
Th1-Th2 Balance
Balance Th1 - Th2
Colombia
description ABSTRACT: Introduction: Cervical cancer is characterized by an immunosuppressive microenvironment and a Th2-type cytokine profile. Expression of arginase (ASE), the enzyme that converts L-arginine into L-ornithine and urea, is stimulated by Th2-type cytokines. Objective: To assess the association of ASE activity and L-Arg metabolism products with cervical cancer. Methods: Sera of 87 and 41 women with histologically confirmed by colposcopy-directed biopsy SCC and CIN3 respectively and 79 with normal cytology or Low-Grade Squamous Intraepithelial Lesion (LSIL), were evaluated. Cytokines were measured using Milliplex Human cytokine/chemokine kit. Arginase (ASE) activity was determined using an enzymatic assay. Levels of L-arginine, L ornithine, putrescine and spermine were determined by HPLC. Results: Significantly higher levels of ASE activity were observed in women with CIN3 (age-adjusted OR: 24.3; 95%CI: 3.82–155) and SCC (AOR: 9.8; 95%CI: 2.34–40.8). As expected, possibly due to high levels of ASE activity, higher levels of L-Arg were negatively associated with CIN3 (AOR: 0.03; 95%CI: 0.004–0.19) and SSC (AOR: 0.06; 95%CI: 0.02–0.24). Consistent with the role of ASE in the conversion of L-arginine to L-ornithine and polyamine production therefrom, women with cervical cancer had higher levels of spermine and putrescine. A correlation analysis revealed a significant albeit weak relationship between high levels of IL-10 and high levels of ASE (Pearson r = 0.32, p-value = 0.003) in women with cervical cancer. Conclusion: This study indicates that ASE activity and L-Arg degradation mechanisms of immunosuppression are present in cervical cancer. The results foster research in the design of possible strategies to inhibit ASE activity for therapy of cervical cancer.
publishDate 2014
dc.date.issued.none.fl_str_mv 2014
dc.date.accessioned.none.fl_str_mv 2022-11-29T21:46:35Z
dc.date.available.none.fl_str_mv 2022-11-29T21:46:35Z
dc.type.spa.fl_str_mv info:eu-repo/semantics/article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.hasversion.spa.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.coar.spa.fl_str_mv http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.redcol.spa.fl_str_mv https://purl.org/redcol/resource_type/ART
dc.type.local.spa.fl_str_mv Artículo de investigación
format http://purl.org/coar/resource_type/c_2df8fbb1
status_str publishedVersion
dc.identifier.issn.none.fl_str_mv 0090-8258
dc.identifier.uri.none.fl_str_mv https://hdl.handle.net/10495/32451
dc.identifier.doi.none.fl_str_mv 10.1016/j.ygyno.2014.07.096
dc.identifier.eissn.none.fl_str_mv 1095-6859
dc.identifier.url.spa.fl_str_mv https://www.sciencedirect.com/science/article/pii/S0090825814012190?via%3Dihub
identifier_str_mv 0090-8258
10.1016/j.ygyno.2014.07.096
1095-6859
url https://hdl.handle.net/10495/32451
https://www.sciencedirect.com/science/article/pii/S0090825814012190?via%3Dihub
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.ispartofjournalabbrev.spa.fl_str_mv Gynecol. Oncol.
dc.rights.spa.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.uri.*.fl_str_mv http://creativecommons.org/licenses/by-nc-nd/2.5/co/
dc.rights.accessrights.spa.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.creativecommons.spa.fl_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
rights_invalid_str_mv http://creativecommons.org/licenses/by-nc-nd/2.5/co/
http://purl.org/coar/access_right/c_abf2
https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.format.extent.spa.fl_str_mv 7
dc.format.mimetype.spa.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Elsevier
dc.publisher.group.spa.fl_str_mv Infección y Cáncer
dc.publisher.place.spa.fl_str_mv Nueva York, Estados Unidos
institution Universidad de Antioquia
bitstream.url.fl_str_mv https://bibliotecadigital.udea.edu.co/bitstream/10495/32451/1/BedoyaAstrid_2014_ImmunosuppressionCervicalCancer.pdf
https://bibliotecadigital.udea.edu.co/bitstream/10495/32451/2/license_rdf
https://bibliotecadigital.udea.edu.co/bitstream/10495/32451/3/license.txt
bitstream.checksum.fl_str_mv 859ae06c86a4cb0202e8857f96a59ff6
b88b088d9957e670ce3b3fbe2eedbc13
8a4605be74aa9ea9d79846c1fba20a33
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositorio Institucional Universidad de Antioquia
repository.mail.fl_str_mv andres.perez@udea.edu.co
_version_ 1805390214187712512
spelling Bedoya, Astrid MilenaTate, DavidBaena Zapata, ArmandoCórdoba Gómez, Carlos MarioBorrero Franco, MauricioPareja, RenéRojas, FredyPatterson, JohnHerrero, RolandoZea, ArnoldSánchez Vásquez, Gloria Inés2022-11-29T21:46:35Z2022-11-29T21:46:35Z20140090-8258https://hdl.handle.net/10495/3245110.1016/j.ygyno.2014.07.0961095-6859https://www.sciencedirect.com/science/article/pii/S0090825814012190?via%3DihubABSTRACT: Introduction: Cervical cancer is characterized by an immunosuppressive microenvironment and a Th2-type cytokine profile. Expression of arginase (ASE), the enzyme that converts L-arginine into L-ornithine and urea, is stimulated by Th2-type cytokines. Objective: To assess the association of ASE activity and L-Arg metabolism products with cervical cancer. Methods: Sera of 87 and 41 women with histologically confirmed by colposcopy-directed biopsy SCC and CIN3 respectively and 79 with normal cytology or Low-Grade Squamous Intraepithelial Lesion (LSIL), were evaluated. Cytokines were measured using Milliplex Human cytokine/chemokine kit. Arginase (ASE) activity was determined using an enzymatic assay. Levels of L-arginine, L ornithine, putrescine and spermine were determined by HPLC. Results: Significantly higher levels of ASE activity were observed in women with CIN3 (age-adjusted OR: 24.3; 95%CI: 3.82–155) and SCC (AOR: 9.8; 95%CI: 2.34–40.8). As expected, possibly due to high levels of ASE activity, higher levels of L-Arg were negatively associated with CIN3 (AOR: 0.03; 95%CI: 0.004–0.19) and SSC (AOR: 0.06; 95%CI: 0.02–0.24). Consistent with the role of ASE in the conversion of L-arginine to L-ornithine and polyamine production therefrom, women with cervical cancer had higher levels of spermine and putrescine. A correlation analysis revealed a significant albeit weak relationship between high levels of IL-10 and high levels of ASE (Pearson r = 0.32, p-value = 0.003) in women with cervical cancer. Conclusion: This study indicates that ASE activity and L-Arg degradation mechanisms of immunosuppression are present in cervical cancer. The results foster research in the design of possible strategies to inhibit ASE activity for therapy of cervical cancer.COL00123287application/pdfengElsevierInfección y CáncerNueva York, Estados Unidosinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://purl.org/coar/resource_type/c_2df8fbb1https://purl.org/redcol/resource_type/ARTArtículo de investigaciónhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by-nc-nd/2.5/co/http://purl.org/coar/access_right/c_abf2https://creativecommons.org/licenses/by-nc-nd/4.0/Immunosuppression in Cervical Cancer with Special Reference to Arginase ActivityUterine Cervical NeoplasmsNeoplasias del Cuello UterinoArginaseArginasaArginineArgininaCytokinesCitocinasTh1-Th2 BalanceBalance Th1 - Th2ColombiaGynecol. Oncol.Gynecologic Oncology74801351ORIGINALBedoyaAstrid_2014_ImmunosuppressionCervicalCancer.pdfBedoyaAstrid_2014_ImmunosuppressionCervicalCancer.pdfArtículo de investigaciónapplication/pdf434633https://bibliotecadigital.udea.edu.co/bitstream/10495/32451/1/BedoyaAstrid_2014_ImmunosuppressionCervicalCancer.pdf859ae06c86a4cb0202e8857f96a59ff6MD51CC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8823https://bibliotecadigital.udea.edu.co/bitstream/10495/32451/2/license_rdfb88b088d9957e670ce3b3fbe2eedbc13MD52LICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://bibliotecadigital.udea.edu.co/bitstream/10495/32451/3/license.txt8a4605be74aa9ea9d79846c1fba20a33MD5310495/32451oai:bibliotecadigital.udea.edu.co:10495/324512022-11-29 16:46:35.801Repositorio Institucional Universidad de Antioquiaandres.perez@udea.edu.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